| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie's notable advancements in immunology and neuroscience are at the forefront of its product/service development, with a strong pipeline promising future growth. The company's focus on innovative therapies enhances its competitive edge and market position. Furthermore, the potential for new product launches drives optimism among stakeholders. However, navigating regulatory hurdles and evolving market dynamics remains critical to sustaining development momentum. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at -0 on 2025-11-08. The forces of and Valuation Sentiment (-0.1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.9) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-08 | 0%(0%) | 0 | 0% | 0.6 | 3.9 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 0 | 0% | 0.5 | 4.1 | -1 | |||||||
| 2025-11-06 | 0%(0%) | 0 | 0% | 0.5 | 3.8 | -1 | |||||||
| 2025-11-05 | 0%(0%) | 0 | 0% | 0.5 | 4 | -1 | |||||||
| 2025-11-04 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -1 | |||||||
| 2025-11-03 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -1 | |||||||
| 2025-11-02 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-11-01 | 0%(0%) | 0 | 0% | 0.3 | 3 | 7 | |||||||
| 2025-10-31 | 0%(0%) | 0 | 0% | 0.3 | 2.7 | -1.5 | |||||||
| 2025-10-30 | 0%(0%) | 0 | 0% | 0.3 | 2.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-08 17:02:11 The article touches on investor sentiment towards both companies, reflecting a shift in preferences towards AbbVie based on current financial performance. |
| 2025-11-08 17:02:11 The discussion involves the competitive landscape, with AbbVie being viewed more favorably than Pfizer in terms of earnings and dividend reliability. |
| 2025-11-08 17:02:11 The article compares the dividend payouts of AbbVie and Pfizer, suggesting AbbVie as a more favorable option based on dividend stability and growth potential. |
| 2025-11-08 17:02:11 The valuation metrics of both companies are analyzed, highlighting AbbVie's potential upside versus Pfizer's low valuation appearing attractive to value investors. |
| 2025-11-08 17:02:11 The article discusses the Q3 earnings of AbbVie and Pfizer, indicating positive performance for AbbVie and concerns for Pfizer. |